Adverse effects in women: implications for drug development and regulatory policies

Sex Differences in Pharmacokinetics and Pharmacodynamics

(2009) Offie P. Soldin et al.   CLINICAL PHARMACOKINETICS

Drug Safety and the Role of Clinical Pharmacology in the Safe Use of Therapeutics

(2009) PK Honig   CLINICAL PHARMACOLOGY & THERAPEUTICS

Perspectives on Early Communication of Drug Risks to the Public

(2009) PJ Seligman et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Participation of Women in Clinical Trials for New Drugs Approved by the Food and Drug Administration in 2000–2002

(2009) Yongsheng Yang et al.   JOURNAL OF WOMENS HEALTH

The FDA Critical Path Initiative and Its Influence on New Drug Development

(2008) Janet Woodcock et al.   Annual Review of Medicine

Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)

(2008) S. E. Kahn et al.   DIABETES CARE